IN8Bio Competitors and Similar CompaniesClear all
IN8Bio's competitors and similar companies include Revolution Medicines.
 IN8Bio IN8Bio (formerly known as Innatus Therapeutics, Incysus Therapeutics) is a clinical-stage biopharmaceutical company focused on the development of gamma-delta T cell therapies for the treatment of cancer. |  Revolution Medicines Revolution Medicines (RevMed) is a clinical-stage oncology company that develops therapies for cancer patients. | |
Founding Date | Founding Date 2016 | Founding Date 2014 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations New York, US HQ Birmingham, US | Locations Redwood City, US HQ Redwood City, US |
Employees | Employees 13 | Employees 37854% increase |
Valuation ($) | Valuation ($) 19.9 m | Valuation ($) 8.4 b |
Financial | ||
Net income | Net income ($19.4m) (FY, 2025) | Net income ($1.1b) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 35m | Total funding raised $ 226m |
For sources of this data, please see the company profile
View Company Profiles
Revolution Medicines
HQ
Redwood City, US
Employees
378
Revolution Medicines (RevMed) is a clinical-stage oncology company that develops therapies for cancer patients.
View company